SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001161697-15-000396
Filing Date
2015-09-16
Accepted
2015-09-16 17:06:51
Documents
1
Period of Report
2015-09-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 form_3.html 3  
1 FORM 3 form_3.xml 3 4805
  Complete submission text file 0001161697-15-000396.txt   6423
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Issuer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 FORT LAUDERDALE FL 33134
Business Address
Merrigan Paul J (Reporting) CIK: 0001653275 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33057 | Film No.: 151110795